(1)
BIOTECHNOLOGY-DRIVEN VACCINE MANUFACTURING AND QUALITY CONTROL FOR CARDIOVASCULAR PROTECTION: CHALLENGES AND PUBLIC HEALTH OPPORTUNITIES. Biosci. Insights. 2026, 3 (02), 208-223.